Research graph
References from Safety of Sabin-derived inactivated poliovirus vaccine in adult booster recipients: a systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Apparent global interruption of wild poliovirus type 2 transmission
2001 · External reference
Possible eradication of wild poliovirus type 3—worldwide, 2012
2014 · External reference
Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication
10.1016/j.vaccine.2009.02.071 · 2009 · External reference
Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance
10.1128/jvi.02122-08 · 2009 · External reference
Current and nextgeneration formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
10.1080/21645515.2022.2154100 · 2022 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
Rayyan—a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · 2016 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
10.1136/bmj.39489.470347.ad · 2008 · External reference
Version 5
2020 · External reference
Immunogenicity and safety of inactivated Sabin-strain polio vaccine “PoliovacSin”: clinical trials phase I and II
10.3390/vaccines9060565 · 2021 · External reference
Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: a randomized, observer-blind, controlled phase 1/2 trial
10.1016/j.vaccine.2020.05.081 · 2020 · External reference
Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I trial in healthy adults in Cuba
10.1016/j.vaccine.2014.07.109 · 2014 · External reference
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults
10.1016/j.vaccine.2013.09.021 · 2013 · External reference
Mucosal immune response to poliovirus vaccines in childhood
10.1093/clinids/6.supplement_2.s361 · 1984 · External reference
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER. C6® cell-line: a phase 1 randomized controlled trial in adults
10.1080/21645515.2020.1812315 · 2021 · External reference
Safety profile of Infanrix hexa−17 years of GSK's passive post-marketing surveillance
10.1080/14760584.2020.1800458 · 2020 · External reference
Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: a randomized, observer-blind, controlled phase 1/2 trial
10.1016/j.vaccine.2020.05.081 · 2020 · External reference
